MorphoSys shares jump on expanded antibody discovery deal with Novartis; Pfizer, Auxilium wrap Xiaflex collaboration; New biomarker for diabetes risk;

Conversation on Twitter :

Biotech News

 @FierceBiotech: Test could detect a range of cancers weeks before symptoms. More | Follow @FierceBiotech

 @JohnCFierce: Are clinical trial investigators guilty of mission creep? Report | Follow @JohnCFierce

 @RyanMFierce: Maverix enters genomics software game with Silicon Valley sizzle. More | Follow @RyanMFierce

> Shares of MorphoSys AG got a boost after the biotech announced that it would expand its antibody discovery pact with Novartis ($NVS). The financial terms were not disclosed. Story

> Auxilium and Pfizer ($PFE) are wrapping up their EU collaboration on the Dupuytren's treatment Xiaflex, with marketing rights reverting back to Auxilium. Report

> Vectura filed its marketing application for the COPD drug QVA149 in Japan. Story

Pharma News

@FiercePharma: Are you ready, Humira? Pfizer nabs FDA blessing for blockbuster hopeful Xeljanz, for rheumatoid arthritis. Story | Follow @FiercePharma

> Roche's souped-up breast cancer drug steps on FDA fast track. Item

> Obama's re-elected. So what's next for pharma? Story

> Exec says GSK is back on the straight and narrow. Report

Medical Device News

 @FierceMedDev: BSX study shows improved defibrillator programming reduces unnecessary jolts as well as risk of death. More | Follow @FierceMedDev

 @MarkHFierce: BD ended its 2012 fiscal year on a down note. But CE Forlenza qualifies it as a "solid finish." News | Follow @MarkHFierce

 @DamianFierce: Medical device manufacturer Onyx got snapped up for $43.25M by Sparton. Story | Follow @DamianFierce

> Mindray tanks on disappointing Q3. Article

> Medtronic-backed study supports greater use of CRT pacemakers. Story

> Study: Valves & stents often win FDA nod without proving they improve care. Item

Drug Delivery News

> Hydrogel time bombs set off explosive drug release. Story

> Novartis submits COPD combination inhaler in Japan. Item

> $1M Gates Foundation grant to formulate lifesaving oxytocin. News

Biomarkers News

> Bowel cancer biomarkers from Down Under catch U.S. attention. Item

> Blood protein tags progression in ALS. Article

> Phase III finding points to masitinib CDx for pancreatic cancer. Story

> Breast cancer biomarkers predict tamoxifen response. Report

> Simple blood count points to survival in aggressive skin cancer. News

And Finally… Investigators say that a protein called SFRP4 in the blood can serve as an efficient biomarker to flag a high risk of diabetes. Release

 

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.